monia cases from each period. Hospital-acquired pneumonias were excluded as were cases with initial therapy based on known pathogens. CAP cases were entered into a database and sorted by initial antibiotic therapy and eventual duration.
Results:
Year National Taiwan University Hospital, Taiwan Background and Aims: Mycobacterium kansasii (MK) is one of the most virulent nontuberculosis mycobacteria (NTM) species, yet single MK isolate in multiple sputum samples is still unable to establish the diagnosis of pulmonary disease (PD) based on current guidelines. This study aimed to evaluate the predictors of developing MK-PI within 1 year for subjects with single MK isolate, with a special emphasis on concomitant presence of other NTM species in sputum.
Methods: Patients with a single MK isolate from at least three sputum samples collected within three months from 2008 to 2016 were retrieved from six hospitals in Taiwan. Those with ≥2 follow-up sputum samples and chest radiography in the subsequent 9 months were included for finial analysis. The primary outcome was development of MK-PI during follow-up, and the secondary outcome was radiographic progression. Independent outcome predictors were investigated by multivariate logistic regression analysis.
Results: A total of 84 episodes of single MK isolate at the initial 3 months from 83 cases were analyzed. The mean age was 69.4 AE 19.0, with a male/female ratio of 1.9. Within one year, 17 (20%) episodes progressed to MK-PD; risk factors included high acid-fast smear (AFS) grade (≥3), elementary occupation workers, and initial radiographic score > 6, whereas coexistence with other NTM species was protective. Among patients who developed MK-PD, all experienced radiographic progression, and 41% died within 1 year.
Conclusion:
Although a single MK isolation does not fulfil the diagnostic criteria of MK-PD, this disease may develop if the initial sputum AFS grade is high, initial radiographic score >6, patient has elementary occupations, and no concomitant NTM species other than MK are present. Early anti-MK treatment should be considered for high-risk patients. 
